Search Results - "GODDARD, A. C"

Refine Results
  1. 1

    A comparison of linear and branched polyethylenimine (PEI) with DCChol/DOPE liposomes for gene delivery to epithelial cells in vitro and in vivo by WISEMAN, J. W, GODDARD, C. A, MCLELLAND, D, COLLEDGE, W. H

    Published in Gene therapy (01-09-2003)
    “…Polyethylenimine (PEI), a polycation with high ionic charge density, has recently been used as a gene therapy delivery agent. We have defined the optimal…”
    Get full text
    Journal Article
  2. 2

    Repeat administration of DNA/liposomes to the nasal epithelium of patients with cystic fibrosis by HYDE, S. C, SOUTHERN, K. W, EGAN, J. J, SORGI, F. L, HUANG, L, CUTHBERT, A. W, EVANS, M. J, COLLEDGE, W. H, HIGGINS, C. F, WEBB, A. K, GILL, D. R, GILEADI, U, FITZJOHN, E. M, MOFFORD, K. A, WADDELL, B. E, GOOI, H. C, GODDARD, C. A, HANNAVY, K, SMYTH, S. E

    Published in Gene therapy (01-07-2000)
    “…The major cause of mortality in patients with cystic fibrosis (CF) is lung disease. Expression of the cystic fibrosis transmembrane conductance regulator…”
    Get full text
    Journal Article
  3. 3

    Physiological consequences of the P2328S mutation in the ryanodine receptor (RyR2) gene in genetically modified murine hearts by Goddard, C.A, Ghais, N.S, Zhang, Y, Williams, A.J, Colledge, W.H, Grace, A.A, Huang, C.L.-H

    Published in Acta Physiologica (01-10-2008)
    “…To explore the physiological consequences of the ryanodine receptor (RyR2)-P2328S mutation associated with catecholaminergic polymorphic ventricular…”
    Get full text
    Journal Article
  4. 4

    Arrhythmogenic mechanisms in the isolated perfused hypokalaemic murine heart by Killeen, M. J., Thomas, G., Gurung, I. S., Goddard, C. A., Fraser, J. A., Mahaut-Smith, M. P., Colledge, W. H., Grace, A. A., Huang, C. L.-H.

    Published in Acta Physiologica (01-01-2007)
    “…Aim:  Hypokalaemia is associated with a lethal form of ventricular tachycardia (VT), torsade de pointes, through pathophysiological mechanisms requiring…”
    Get full text
    Journal Article
  5. 5

    Increased persistence of lung gene expression using plasmids containing the ubiquitin C or elongation factor 1α promoter by GILL, D. R, SMYTH, S. E, GODDARD, C. A, PRINGLE, I. A, HIGGINS, C. F, COLLEDGE, W. H, HYDE, S. C

    Published in Gene therapy (01-10-2001)
    “…For effective gene therapy of chronic disease, persistent transgene expression at therapeutic levels is required. Clinical studies of airway gene transfer in…”
    Get full text
    Journal Article
  6. 6

    Optimisation of real-time quantitative RT-PCR for the evaluation of non-viral mediated gene transfer to the airways by ROSE, A. C, GODDARD, C. A, COLLEDGE, W. H, CHENG, S. H, GILL, D. R, HYDE, S. C

    Published in Gene therapy (01-10-2002)
    “…Naked plasmid DNA and DNA/liposome complexes are currently being considered as gene therapy treatments for cystic fibrosis (CF) pulmonary disease. Current…”
    Get full text
    Journal Article
  7. 7

    Steroid hormone enhancement of gene delivery to a human airway epithelial cell line in vitro and mouse airways in vivo by WISEMAN, J. W, GODDARD, C. A, COLLEDGE, W. H

    Published in Gene therapy (01-10-2001)
    “…Current liposome-based delivery protocols for gene therapy are relatively inefficient. In a pharmacological approach to enhance liposome-mediated gene delivery…”
    Get full text
    Journal Article
  8. 8

    A second dose of a CFTR cDNA-liposome complex is as effective as the first dose in restoring cAMP-dependent chloride secretion to null CF mice trachea by GODDARD, C. A, RATCLIFF, R, CUTHBERT, A. W, EVANS, M. J, COLLEDGE, W. H, ANDERSON, J. R, GLENN, E, BROWN, S, GILL, D. R, HYDE, S. C, MACVINISH, L. J, HUANG, L, HIGGINS, C. F

    Published in Gene therapy (01-11-1997)
    “…Phase I clinical trials have provided encouraging data suggesting that gene transfer could provide a treatment for cystic fibrosis (CF). However, for all the…”
    Get full text
    Journal Article
  9. 9

    A murine tracheal culture system to investigate parameters affecting gene therapy for cystic fibrosis by SCOTT, E. S, GODDARD, C. A, WISEMAN, J. W, EVANS, M. J, COLLEDGE, W. H

    Published in Gene therapy (01-04-2000)
    “…Cystic fibrosis (CF) is a life-threatening condition caused by mutations in the cystic fibrosis transmembrane conductance regulator gene (CFTR). Delivery of…”
    Get full text
    Journal Article
  10. 10

    Potential Contribution of Combined Atmospheric Ca2+ and Mg2+ Wet Deposition Within the Continental U.S. to Soil Inorganic Carbon Sequestration by MIKHAILOVA, E.A., GODDARD, M.A., POST, C.J., SCHLAUTMAN, M.A., GALBRAITH, J.M.

    Published in Pedosphere (01-12-2013)
    “…Soil inorganic carbon (SIC) stocks continuously change from the formation of pedogenic carbonates, a process requiring inputs of Ca2+ and Mg2+ ions. This study…”
    Get full text
    Journal Article
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16

    Parallel midbrain microcircuits perform independent temporal transformations by Goddard, C Alex, Huguenard, John, Knudsen, Eric

    Published in The Journal of neuroscience (11-06-2014)
    “…The capacity to select the most important information and suppress distracting information is crucial for survival. The midbrain contains a network critical…”
    Get full text
    Journal Article
  17. 17

    Genistein activates CFTR-mediated Cl(-) secretion in the murine trachea and colon by Goddard, C A, Evans, M J, Colledge, W H

    “…The action of the isoflavone genistein on the cystic fibrosis transmembrane conductance regulator (CFTR) has been studied in many cell systems but not in…”
    Get more information
    Journal Article
  18. 18
  19. 19

    Applications of Imaging Spectroscopy in Molecular Biology II. Colony Screening Based on Absorption Spectra by Arkin, Adam P, Goldman, Ellen R, Robles, Steven J, Goddard, Christine A, Coleman, William J, Yang, Mary M, Youvan, Douglas C

    Published in Bio/technology (New York, N.Y. 1983) (01-08-1990)
    “…Digital imaging spectroscopy has been used to obtain the grayscale spectrum of colored bacterial colonies directly from petri dishes. Up to 500 individual…”
    Get full text
    Journal Article
  20. 20

    Increased persistence of lung gene expression using plasmids containing the ubiquitin C or elongation factor1α promoter by Gill, DR, Smyth, SE, Goddard, CA, Pringle, IA, Higgins, CF, Colledge, WH, Hyde, SC

    Published in Gene therapy (01-10-2001)
    “…For effective gene therapy of chronic disease, persistent transgene expression at therapeutic levels is required. Clinical studies of airway gene transfer in…”
    Get full text
    Journal Article